BORDETELLA CYCLASE-STRUCTURE AND BIOLOGICAL ACTIVITIES
BORDETELLA CYCLASE-STRUCTURE AND BIOLOGICAL ACTIVITIES
批准号:
6843723
负责人:
ERIK L HEWLETT
金额:
$37.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-09-01 至 2006-07-14
关键词:
Bordetella pertussisadenylate cyclasebacterial proteinsbacterial toxinscell membraneconformationcyclic AMPcytoplasmdimerelectron spin resonance spectroscopyenzyme activityenzyme mechanismenzyme structureflow cytometryfluorescence resonance energy transferhemolysinhemolysishost organism interactionlaboratory mousepotassium channelprotein protein interactionprotein structure functionvirulence
中文摘要
描述(摘自申请者摘要):腺苷环化酶毒素
(ACT)是波尔德氏菌产生的一种迷人的细菌毒力因子
百日咳。它具有不同寻常的特点,这使它成为
研究几种毒素家族的作用。ACT是一种1706种氨基酸
具有腺化环化酶结构域的蛋白质,负责催化
CAMP被输送到靶细胞胞浆后的产生
手机。此外,该分子也是细菌rtx家族的一员。
毒素和蛋白质,以其钙结合重复序列为特征。许多.
该家族的成员是形成孔洞的溶血素和细胞毒素,ACT也是
溶血,显然是通过在宿主细胞中形成一个低聚孔来实现的
薄膜。此外,这种毒素还能引起宿主细胞K+外流。
先于低聚物形成并可与低聚物形成分离的过程。完成工作
过去几年来,人们认识到,ACT的这些活动是
分开的和不同的。作为回应,下一阶段的目标是
正在进行的项目是了解毒素作用的各个步骤以及如何
它们相互关联。
为了实现这一目标,本研究将遵循以下具体目标:1)
ACT制备时的物理表征和对是否
任何或所有的活性都取决于二聚体的形成。
毒素;2)评估ACT与靶细胞的初始相互作用,
在任何膜植入之前,使用方法来定义早期步骤
发生;3)映射以了解毒素的哪一部分被插入到
膜,使用电子顺磁共振(EPR)光谱,以及
确定该事件与K+流出的关系;4)映射
被传递到细胞质的催化结构域的一部分
中毒与K+外排/溶血是否相互作用的探讨
任何单一毒素分子的独家事件;以及5)表征
寡聚过程和所涉及的毒素结构域。
这项工作旨在了解这种毒素的作用机制。
一个非常基本的水平,有新的方法和技术。结果将是
确定这种毒素在百日咳发病机制中的重要作用
作为一项新的生物医学研究,更好地了解它的行为
将外来抗原运送到宿主免疫系统的探测器和载体。
此外,从拟议研究中获得的信息将有助于
到一般的毒素研究领域,在这个领域中有许多例子
大的外源蛋白通过不完全的方式进入宿主细胞
了解各种机制。
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Adenylate cyclase toxin
(ACT) is a fascinating bacterial virulence factor produced by Bordetella
pertussis. It has unusual features, which make it an important prototype for
study of the actions of several families of toxins. ACT is a 1706 amino acid
protein that possesses an adenylate cyclase domain responsible for catalyzing
the production of cAMP after it is delivered to the cytoplasm of the target
cell. In addition, this molecule is a member of the RTX family of bacterial
toxins and proteins, characterized by their calcium-binding repeats. Many of
the family members are pore-forming hemolysins and cytotoxins and ACT is also
hemolytic, apparently by formation of an oligomeric pore in the host cell
membrane. In addition, this toxin elicits K+ efflux from host cells in a
process that precedes and can be dissociated from oligomer formation. Work over
the last several years has led to recognition that these activities of ACT are
separate and distinct. In response, the objective of the next phase of this
ongoing project is to understand the individual steps of toxin action and how
they relate to one another.
To accomplish this goal, the research will follow these Specific Aims: 1)
physical characterization of ACT as it is prepared and evaluation of whether
any or all of the activities are dependent on the formation of dimers by the
toxin; 2) evaluation of the initial interaction of ACT with the target cell,
using methods to define the early step before any membrane insertion is able to
occur; 3) mapping to learn which portion of the toxin is inserted into the
membrane, using electron paramagnetic resonance (EPR) spectroscopy, and
determination of the relationship of that event to K+ efflux; 4) mapping of the
portion of the catalytic domain which is delivered to the cytoplasm and
investigation of whether intoxication and K+ efflux/hemolysis are mutually
exclusive events for any single toxin molecule; and 5) characterization of the
process of oligomerization and the domains of the toxin involved.
This work is directed at understanding the mechanism of action of this toxin at
a very basic level, with novel approaches and technologies. The results will be
important for defining the role of this toxin in the pathogenesis of pertussis
and for gaining better knowledge of its actions as a novel biomedical research
probe and vehicle for delivery of foreign antigens to the host immune system.
In addition, the information acquired from the proposed studies will contribute
to the general field of toxin research, in which there are many examples of
large extrinsic proteins gaining access to host cells by incompletely
understood mechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
11th International Symposium on Bordetella
-
批准号:9053803
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2016
-
负责人:ERIK L HEWLETT
-
依托单位:
Integrated analysis of cellular responses to toxins from clostridium difficile
-
批准号:8233381
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2011
-
负责人:ERIK L HEWLETT
-
依托单位:
Bordetella cyclase toxin: effects on leukocytes and respiratory epithelial cells
-
批准号:7846692
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2009
-
负责人:ERIK L HEWLETT
-
依托单位:
Integrated analysis of cellular responses to toxins from clostridium difficile
-
批准号:7670083
-
项目类别:
-
资助金额:$32.26万
-
财政年份:2009
-
负责人:ERIK L HEWLETT
-
依托单位:
Anthrax
-
批准号:7678783
-
项目类别:
-
资助金额:$51.16万
-
财政年份:2008
-
负责人:ERIK L HEWLETT
-
依托单位:
8th International Symposium - Saga of the Genus Bordetella, 1906-2006
-
批准号:7230901
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2006
-
负责人:ERIK L HEWLETT
-
依托单位:
Seventh International Symposium on Pertussis
-
批准号:6557658
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2002
-
负责人:ERIK L HEWLETT
-
依托单位:
1998 GORDON CONFERENCE-MICROBIAL TOXINS & PATH
-
批准号:2670026
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1998
-
负责人:ERIK L HEWLETT
-
依托单位:
General Clinical Research Center
-
批准号:7591148
-
项目类别:
-
资助金额:$478.77万
-
财政年份:1997
-
负责人:ERIK L HEWLETT
-
依托单位:
General Clinical Research Center
-
批准号:7821393
-
项目类别:
-
资助金额:$493.14万
-
财政年份:1997
-
负责人:ERIK L HEWLETT
-
依托单位:
General Clinical Research Center
-
批准号:7229536
-
项目类别:
-
资助金额:$460.5万
-
财政年份:1997
-
负责人:ERIK L HEWLETT
-
依托单位:
General Clinical Research Center
-
批准号:7408527
-
项目类别:
-
资助金额:$464.83万
-
财政年份:1997
-
负责人:ERIK L HEWLETT
-
依托单位:
BIOLOGICAL EFFECTS OF PERTUSSIS TOXIN B-OLIGOMER
-
批准号:2066121
-
项目类别:
-
资助金额:$27.58万
-
财政年份:1991
-
负责人:ERIK L HEWLETT
-
依托单位:
BIOLOGICAL EFFECTS OF PERTUSSIS TOXIN B-OLIGOMER
-
批准号:3146144
-
项目类别:
-
资助金额:$25.57万
-
财政年份:1991
-
负责人:ERIK L HEWLETT
-
依托单位:
BIOLOGICAL EFFECTS OF PERTUSSIS TOXIN B-OLIGOMER
-
批准号:3146145
-
项目类别:
-
资助金额:$26.55万
-
财政年份:1991
-
负责人:ERIK L HEWLETT
-
依托单位:
BIOLOGICAL EFFECTS OF PERTUSSIS TOXIN B-OLIGOMER
-
批准号:3146146
-
项目类别:
-
资助金额:$27.43万
-
财政年份:1991
-
负责人:ERIK L HEWLETT
-
依托单位:
DIABETES ENDOCRINOLOGY RESEARCH CENTER
-
批准号:3102135
-
项目类别:
-
资助金额:$39.2万
-
财政年份:1987
-
负责人:ERIK L HEWLETT
-
依托单位:
BORDETELLA CYCLASE: STRUCTURE AND BIOLOGICAL ACTIVITY
-
批准号:3127627
-
项目类别:
-
资助金额:$21.19万
-
财政年份:1980
-
负责人:ERIK L HEWLETT
-
依托单位:
BORDETELLA CYCLASE: STRUCTURE AND BIOLOGICAL ACTIVITY
-
批准号:3127628
-
项目类别:
-
资助金额:$22.55万
-
财政年份:1980
-
负责人:ERIK L HEWLETT
-
依托单位:
BORDETELLA CYCLASE--STRUCTURE AND BIOLOGICAL ACTIVITIES
-
批准号:2607735
-
项目类别:
-
资助金额:$30.51万
-
财政年份:1980
-
负责人:ERIK L HEWLETT
-
依托单位:
海外基金